BAX : Summary for Baxter International Inc. Commo - Yahoo Finance

U.S. Markets closed

Baxter International Inc. (BAX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
51.98+0.09 (+0.17%)
At close: 4:00PM EDT

51.98 0.00 (0.00%)
After hours: 4:37PM EDT

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close51.89
Bid0.00 x
Ask0.00 x
Day's Range51.56 - 52.19
52 Week Range40.52 - 52.33
Avg. Volume2,786,362
Market Cap28.17B
PE Ratio (TTM)5.77
Earnings DateN/A
Dividend & Yield0.52 (1.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 days ago

    Alexion Pharma names former Baxalta chief Ludwig Hantson CEO

    Alexion Pharmaceuticals Inc on Monday named former Baxalta CEO Ludwig Hantson to its top job, as the rare-disease drug maker seeks to regain investor confidence following the exit of top management. Hantson's appointment comes after a challenging few months for the U.S. biotech. Alexion's flagship drug Soliris, which treats two rare blood disorders, has fueled much of the company's growth, but looming competition and the drug's slowing sales growth in recent quarters have made investors jittery.

  • Business Wire7 days ago

    Baxter International Inc. to Host First Quarter 2017 Financial Results Conference Call for Investors

    Baxter International Inc. , will host a quarterly conference call to discuss its first quarter 2017 financial results on Wednesday, April 26, 2017, at 7:30 a.m. Central Standard Time.

  • TheStreet.com9 days ago

    Baxter's Chart Is Still Bullish

    Our price objective is $68.